THE PSCI PRESENTS ITS SECOND PUBLIC AUDIT FINDINGS REPORT, PROVIDING CONTINUED INSIGHTS INTO SUPPLIER RISKS, TRENDS, AND AREAS FOR IMPROVEMENT ACROSS THE PHARMACEUTICAL AND HEALTHCARE SUPPLY CHAIN.

Every year, pharmaceutical and healthcare companies carry out thousands of audits around the world to ensure that their suppliers are meeting expectations around Health, Safety, and Environmental topics, amongst others. These audits represent a significant investment of time and financial resources both for the company and the supplier. At the PSCI, we aim to support companies and suppliers to collaborate on audits through our shared audit platform and framework.

This report shares our analysis of findings from PSCI audits available on our platform. Each year, we review these in line with the PSCI Principles to identify trends, highlight improvements, and share recommendations. Overall, this analysis provides deep insight into supplier practices within the pharmaceutical and healthcare industry and guides us on developing targeted resources and trainings.

The year’s report analyzes 1,776 findings from 180 supplier audits uploaded to the PSCI platform in 2023. These findings are categorized into 308 Management Systems findings, 7 Ethics findings, 169 Human Rights findings, 970 Health & Safety findings, and 322 Environment findings, offering a comprehensive overview of supplier practices and opportunities for improvement. The report includes a summary of findings across key topics, detailed breakdowns with recommended actions for suppliers, and links to relevant PSCI resources. By identifying patterns, we can develop targeted support through training programs and resources tailored to address specific challenges.

What’s new this year?

• The first-ever analysis by supplier type, providing tailored insights into specific supplier categories.
• A regional analysis focused on major pharmaceutical manufacturing hubs, including China and India.
• A deep-dive analysis of 13 suppliers’ audit data over three years, exploring changes in supplier practices and measuring PSCI’s impact.

Reflecting on the report, Co-lead of the PSCI Audit Committee Dorota Wiacek-Trojanowska, Senior Supplier Sustainability Audit Program Manager at Roche commented,

"We are delighted to invite you to read our comprehensive PSCI Audit Findings Analysis Report, featuring intriguing analyses drawn from a significant number of audits conducted in 2023 in accordance with the PSCI Principles.

We’re pleased that this year’s report includes a new, detailed regional analysis that highlights the main challenges and opportunities for improvement across various geographic regions. Additionally, the report provides a perspective on different supplier categories, offering valuable insights into their specific contexts.

At the PSCI, we use these insights to develop tailored supplier development and improvement activities, including webinars, tools, and resources. By exploring this report, you will gain a deeper understanding of the detailed analyses per Principle, regional coverage, and industry segments, enabling you to identify impactful improvement areas effectively."

The report reinforces the PSCI’s role as a catalyst for continuous improvement, equipping suppliers with tools and guidance to enhance practices and adapt to evolving demands. For more details, access the full report in the resource attached.